Use of soluble CD164 in inflammatory and/or autoimmune disorders

Details for Australian Patent Application No. 2004260835 (hide)

Owner Applied Research Systems ARS Holding N.V.

Inventors Chvatchko, Yolande

Agent Griffith Hack

Pub. Number AU-A-2004260835

PCT Pub. Number WO2005/011728

Priority 03077316.2 23.07.03 EP

Filing date 23 July 2004

Wipo publication date 10 February 2005

International Classifications

A61K 38/17 (2006.01) Medicinal preparations containing peptides - from animals

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 37/04 (2006.01) Drugs for immunological or allergic disorders

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/011728 Priority application(s): WO2005/011728

25 October 2007 Assignment before Grant

  Applied Research Systems ARS Holding N.V. The application has been assigned to Laboratoires Serono SA

18 February 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004260836-2-imino-4-(thio) oxo-5-poly cyclovinylazolines for use as P13 kinase ihibitors

2004260832-Alkaline salts of proton pump inhibitors